The Increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industry-academia collaborations, and the patent expiry of biologics are the major factors driving the growth of the market.
In 2020, the growth factors & chemokines segment accounted for the largest share of the market and is also expected to grow at the highest CAGR during the forecast period.
Based on product, the recombinant proteins market is classified into growth factors and chemokines, structural proteins, kinase proteins, regulatory proteins, membrane proteins, recombinant metabolic enzymes, adhesion molecules and receptors, immune response proteins, and other recombinant proteins. The large share of the growth factors and chemokines segment can be attributed to its use in various research areas such as chemotaxis, neurobiology, wound healing, immunology, transplantation, apoptosis, cancer, HIV/AIDS, COVID-19, cell culture, and stem cell research.
/CNW/ - Verify Diagnostics announced today that Health Canada has authorized the Assure Tech Ecotest COVID-19 serological rapid test to be used at the.
Share this article
Share this article
SPARTANBURG, S.C., Feb. 16, 2021 /PRNewswire/ Contec, Inc., a Spartanburg, SC-based manufacturer of critical cleaning products for the pharmaceutical, med device and healthcare industries and New Jersey based corporate headquarters, Mannington Commercial, one of the world s leading manufacturers of fine flooring, have announced an exclusive alliance in their efforts to better serve the U.S. healthcare industry.
Leveraging their respective strengths, Contec s Professional business unit has agreed to develop and conduct performance-based research on select Mannington Commercial flooring intended for the acute care market. Reciprocally, Mannington Commercial is designating Contec s Premira II® line of
Laundry-Free™ microfiber products as the official disposable line of cleaning pads for use with their high-end flooring. The alliance will also include co-marketing and co-selling efforts between the two companies.
Share this article
Share this article
ResearchAndMarkets.com s offering.
The global PoC molecular diagnostics market will reach $5,665.3 million by 2030, growing by 13.5% annually over 2020-2030 driven by increase in adoption of personalized medicine and surge in usage of PoC molecular diagnostics for drug discovery and development amid COVID-19 pandemic.
This report is based on a comprehensive research of the entire global PoC molecular diagnostics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year.